- Home
- JXN vs BPMC Comparison
JXN vs BPMC Comparison
Compare JXN & BPMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JXN
- BPMC
- Stock Information
- Founded
- JXN 1961
- BPMC 2008
- Country
- JXN United States
- BPMC United States
- Employees
- JXN N/A
- BPMC N/A
- Industry
- JXN Life Insurance
- BPMC Biotechnology: Pharmaceutical Preparations
- Sector
- JXN Finance
- BPMC Health Care
- Exchange
- JXN Nasdaq
- BPMC Nasdaq
- Market Cap
- JXN 6.8B
- BPMC 7.0B
- IPO Year
- JXN N/A
- BPMC 2015
- Fundamental
- Price
- JXN $81.60
- BPMC $92.25
- Analyst Decision
- JXN Hold
- BPMC Buy
- Analyst Count
- JXN 5
- BPMC 19
- Target Price
- JXN $92.80
- BPMC $123.61
- AVG Volume (30 Days)
- JXN 550.4K
- BPMC 1.0M
- Earning Date
- JXN 02-19-2025
- BPMC 02-13-2025
- Dividend Yield
- JXN 3.90%
- BPMC N/A
- EPS Growth
- JXN 9.11
- BPMC N/A
- EPS
- JXN 11.74
- BPMC N/A
- Revenue
- JXN $3,271,000,000.00
- BPMC $508,824,000.00
- Revenue This Year
- JXN N/A
- BPMC $44.29
- Revenue Next Year
- JXN $3.64
- BPMC $32.49
- P/E Ratio
- JXN $6.99
- BPMC N/A
- Revenue Growth
- JXN 3.55
- BPMC 104.04
- 52 Week Low
- JXN $51.59
- BPMC $80.68
- 52 Week High
- JXN $115.22
- BPMC $121.90
- Technical
- Relative Strength Index (RSI)
- JXN 31.68
- BPMC 34.05
- Support Level
- JXN $89.83
- BPMC $90.84
- Resistance Level
- JXN $98.02
- BPMC $96.78
- Average True Range (ATR)
- JXN 3.48
- BPMC 4.34
- MACD
- JXN -1.02
- BPMC -2.26
- Stochastic Oscillator
- JXN 2.61
- BPMC 5.64
About JXN Jackson Financial Inc.
Jackson Financial Inc helps Americans grow and protect their retirement savings and income to enable them to pursue financial freedom for life. Its retail products offerings comprise annuities, designed to help retail investors save for and live in retirement. Its diverse suite of annuities includes a variable, fixed index, and fixed annuities. It manages the business through three segments: Retail Annuities, Institutional Products, and Closed Life and Annuity Blocks and Corporate and Other segments.
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.